Lightbridge shares fell 8.5% after earnings, with investors likely focused on the long and still conditional path from the INL pilot-facility selection to commercial-reactor testing. Construction remains subject to further DOE and INL agreements and approvals, no material construction commitments had been made by September 30, and use of lead test assemblies in commercial reactors would separately require NRC and host-utility approval.
Shares rose 5.7% following a Q2 update that highlighted tangible progress on multiple fronts, notably the removal of irradiated fuel samples and strategic partnerships advancing licensing and commercial preparation.